Sanofi SA's Fiscal Year is From January To December - All Figures are in EUR, Billions.
The item "Other-Stockholder-Equity" stands at 73.53 Billion Euros as of 09/30/2025, the highest value at least since 03/31/2011, the period currently displayed.
As of the end of Sanofi SA's third quarter, the item "Other Stockholder Equity" stands at 73.53 Billion EUR. This represents an increase of 1,452.31 percent compared to it's value at the end of it's second quarter .
Regarding the One-Year-Change of the series, the current value constitutes an increase of 146.22 Billion Euros compared to the value the year prior.
The 1 year change is 146.22 Billion Euros.
The 3 year change is 144.48 Billion Euros.
The 5 year change is 136.84 Billion Euros.
The 10 year change is 130.15 Billion Euros.
| Logo | Name | Market Cap (USD) |
|---|---|---|
![]() | Eli Lilly and Company - Other Stockholder Equity | 905,699,262,464.00 |
![]() | Johnson & Johnson - Other Stockholder Equity | 486,508,953,600.00 |
![]() | AbbVie Inc - Other Stockholder Equity | 399,570,305,024.00 |
![]() | Roche Holding AG - Other Stockholder Equity | 317,433,206,677.55 |
![]() | AstraZeneca PLC - Other Stockholder Equity | 280,205,508,085.11 |